Vaginal misoprostol for late first trimester abortion

Area of Science:

• Reproductive Medicine
• Pharmacology

Background:

• Medical abortion is a crucial aspect of reproductive healthcare.
• Evaluating safe and effective methods for early pregnancy termination is essential.

Purpose of the Study:

• To assess the efficacy and safety of vaginal misoprostol for terminating early gestations (64-84 days).
• To determine the rate of complete abortion without surgical intervention.

Main Methods:

• 120 women with gestations of 64-84 days received 800 mcg vaginal misoprostol every 24 hours for up to three doses.
• Outcomes included successful abortion, side effects, expulsion time, and vaginal bleeding duration.
• No postexpulsion systematic preventive curettage was performed.

Main Results:

• A complete abortion rate of 87% (104/120) was observed.
• Clinically insignificant hemoglobin decrease (12.2 to 11.6 mg/dL) was noted.
• Vaginal bleeding averaged 12 days, with no need for surgical curettage.

Conclusions:

• Vaginal misoprostol is a valid and effective method for interrupting gestations of 10-12 weeks.
• The procedure demonstrates a high success rate with manageable side effects.
• This approach avoids the need for systematic curettage, enhancing patient safety.